logo

For the Inventor, By the Inventor

Saitama, Japan

Shigeyuki Kataoka

This inventor holds 6 USPTO granted patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1977-1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeyuki Kataoka. Retrieved from https://idiyas.com/inventor/shigeyuki-kataoka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 9.1

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Saitama, JA (1977)
  • Iruma, JA (1978)
  • Sakado, JP (1980 - 1982)
  • Saitama, JP (1982)

Company Filing History:

goldMedal6 out of 987 
 
Chugai Seiyaku Kabushiki Kaisha
 patents

Years Active: 1977-1982

Loading Chart...
6 patents (USPTO):Explore Patents
1. 4366161 - Nicotinamide derivative, process for preparing the same and (1982-12-28),
2. 4361572 - Tetrahydronicotinamide derivative, pharmaceutical compositions and use (1982-11-30),
3. 4221814 - Terephthalic acid monoamide derivatives, process for preparing the same, (1980-09-09),
4. 4092431 - Pharmaceutical composition and method of the use thereof (1978-05-30),
5. 4058523 - Bis(benzamido)-benzene derivatives (1977-11-15),
6. 4038416 - Pharmaceutical composition and method of the use thereof (1977-07-26),

Title: Shigeyuki Kataoka: Innovator in Pharmaceutical Chemistry

Introduction

Shigeyuki Kataoka is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work focuses on developing novel compounds that have therapeutic applications.

Latest Patents

Kataoka's latest patents include a nicotinamide derivative and a novel compound, 1,2-bis(nicotinamido)propane, along with its pharmaceutically acceptable salts. These inventions are designed to prevent or spasmolyse cerebral vasospasms, prevent cerebral apoplexy, and lower lipoperoxide levels in the blood. Another notable patent is for a tetrahydronicotinamide derivative, which has been shown to suppress platelet aggregation and exhibit anti-inflammatory, antipyretic, and analgesic actions.

Career Highlights

Kataoka is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His innovative work has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Some of his notable coworkers include Sakae Takaku and Minoru Shindo, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Shigeyuki Kataoka's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…